Stephen DiPalma
Directeur/Membre du Conseil chez Phytera, Inc.
Profil
Stephen J.
DiPalma is the founder of Blueprint Genetics, Inc. (founded in 1988) and Catalyst Oncology, Inc. (founded in 2004).
He held the title of Chief Financial Officer at Blueprint Genetics, Inc. from 1988 to 1995 and the title of President & Chief Executive Officer at Catalyst Oncology, Inc. Mr. DiPalma's current job(s) included being a Director at Phytera, Inc. since 1998 and a Co-Managing Director at Danforth Advisors LLC since 2014.
Mr. DiPalma's former job(s) include being a Director at Cognoptix, Inc., Chief Financial Officer at Aquila Biopharmaceuticals, Inc., Chief Financial Officer at Interleukin Genetics, Inc. from 2014 to 2017, Chief Financial Officer & Senior Vice President at FORUM Pharmaceuticals, Inc. from 2009 to 2014, Chief Financial Officer at Histogenics Corp.
in 2015, Chief Financial Officer & EVP-Business Operations at Galena Biopharma, Inc. in 2009, Chief Financial Officer at Scorpius Holdings, Inc., Chief Financial Officer at Anchiano Therapeutics Ltd.
in 2020, Chief Financial Officer at Milkhaus Laboratory, Inc. from 2002 to 2004, Divisional Controller at The Health Data Institute, Inc., Chief Financial Officer & Treasurer at Spero Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer & Treasurer at Spero Therapeutics, Inc. in 2023, Chief Financial & Accounting Officer at Beyond Air, Inc. in 2018, Treasurer, Chief Financial & Accounting Officer at Solid Biosciences, Inc. from 2021 to 2023, Chief Financial & Accounting Officer at Inozyme Pharma, Inc., Chief Financial & Accounting Officer at Generation Bio Co. from 2019 to 2020, Chief Financial Officer at LAVA Therapeutics NV, Chief Financial Officer at CG Oncology, Inc., and Chief Financial Officer & Treasurer at Foghorn Therapeutics, Inc. in 2024.
Mr. DiPalma's education history includes an MBA from Babson College in 1988 and an undergraduate degree from the University of Massachusetts Lowell.
Postes actifs de Stephen DiPalma
| Sociétés | Poste | Début |
|---|---|---|
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | Directeur/Membre du Conseil | 01/01/1998 |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Corporate Officer/Principal | 01/04/2014 |
Anciens postes connus de Stephen DiPalma
| Sociétés | Poste | Fin |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur Financier/CFO | 16/04/2024 |
| SPERO THERAPEUTICS, INC. | Directeur Financier/CFO | 06/11/2023 |
| SOLID BIOSCIENCES INC. | Directeur Financier/CFO | 09/01/2023 |
| LAVA THERAPEUTICS N.V. | Directeur Financier/CFO | 15/03/2021 |
| SPERO THERAPEUTICS, INC. | Directeur Financier/CFO | 04/01/2021 |
Formation de Stephen DiPalma
| Babson College | Masters Business Admin |
| University of Massachusetts Lowell | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 9 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| GENERATION BIO CO. | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Aquila Biopharmaceuticals, Inc.
 Aquila Biopharmaceuticals, Inc. BiotechnologyHealth Technology Aquila Biopharmaceuticals, Inc. developed and manufactured products for the diagnosis, prevention and treatment of infectious diseases. The company was headquartered in Farmingham, MA. | Health Technology |
Phytera, Inc.
Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | Commercial Services |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Blueprint Genetics, Inc.
 Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Commercial Services |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Health Services |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
Milkhaus Laboratory, Inc.
 Milkhaus Laboratory, Inc. Chemicals: SpecialtyProcess Industries Milkhaus Laboratory, Inc. provides organic chemical products. Its products are used for urological health, skin care, wound care and other healthcare concerns. The company develops drugs based on the theory of systemic signaling, which postulates that therapeutic molecules can send genomic or cellular signals that disrupt the dysfunctional signals causing disease and allow the body to restore healthy signals. Milkhaus Laboratory was founded by Robert W. Middleton in 1993 and is headquartered in Providence, RI. | Process Industries |
| Catalyst Oncology, Inc. | Health Services |
| The Health Data Institute, Inc. | |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Commercial Services |
